BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Lilly declares third-quarter 2025 dividend

  June 24, 2025

   · 

  2 min read
• Press Releases

  Novo Nordisk A/S: Ozempic® receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and comorbidities

  June 24, 2025

   · 

  10 min read
• Press Releases

  Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 23, 2025

  June 24, 2025

   · 

  2 min read
• Press Releases

  Longeveron® Announces Completion of Enrollment of Pivotal Phase 2b Clinical Trial Evaluating Laromestrocel as a Treatment for Hypoplastic Left Heart Syndrome (HLHS)

  June 24, 2025

   · 

  9 min read
• Press Releases

  Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum

  June 24, 2025

   · 

  4 min read
• Press Releases

  Atea Pharmaceuticals Announces Continued Advancement of Global Phase 3 HCV Program with Dosing of First Patient in C-FORWARD Outside North America

  June 24, 2025

   · 

  10 min read
• Press Releases

  Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema

  June 24, 2025

   · 

  5 min read
• Press Releases

  ImmunoPrecise Advances Universal Dengue Vaccine, Confirming Safety, Immune Activation, and Structural Stability Using its LENSai™ Platform Powered by Patented HYFT® Technology

  June 24, 2025

   · 

  8 min read
• Press Releases

  DATROWAY® approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer

  June 24, 2025

   · 

  19 min read
• Press Releases

  Injectable Drugs Market to Reach USD 1,032.78 Billion by 2032, Expanding at a CAGR of 7.7% | Coherent Market Insights

  June 24, 2025

   · 

  1 min read